GlassScriptPhysician profile
Danielle M Dietz
NPI 1558468462
$6,746.03
in general payments reported to CMS, 2019-2025
22 companies · $173 in 2025
The $173 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2020: $25.94 · 2021: $155 · 2022: $639 · 2023: $5,431 · 2024: $176 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Travel and Lodging: $1,144 · Food and Beverage: $635.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Travel and Lodging | $1,144.23 |
| Food and Beverage | $635.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,805.88 | 2019-2023 | Davinci Xi, Da Vinci Surgical System |
| Davol INC. | $154.88 | 2021 | |
| Abbvie INC. | $153.17 | 2023-2024 | Linzess, Creon |
| Ethicon US, LLC | $89.66 | 2019-2025 | Stratafix, Vistaseal, Echelon; Endopath |
| Innovation Technologies INC | $87.38 | 2024-2025 | Irrisept |
| Medtronic, INC. | $60.31 | 2022-2025 | Ligasure |
| Vertex Pharmaceuticals Incorporated | $56.86 | 2025 | |
| Genzyme Corporation | $39.71 | 2023-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $34.13 | 2023 | Entyvio, Gattex |
| Becton, Dickinson and Company | $32.99 | 2025 | Phasix Mesh |
| Osiris Therapeutics INC. | $27.77 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $25.94 | 2020 | |
| Janssen Biotech, INC. | $24.24 | 2023 | Stelara, Simponi, Remicade |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.03 | 2023 | Xifaxan |
| W. L. Gore & Associates, INC. | $19.32 | 2024 | Gore Synecor Biomaterial |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Qol Medical, LLC | $18.97 | 2024 | Sucraid |
| Hologic Sales and Service, LLC | $18.08 | 2023 | Localizer |
| Molnlycke Health Care US, LLC | $17.83 | 2024 | Hubs, Hibiclens |
| Cook Medical LLC | $15.00 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $14.74 | 2023 | Dupixent |
| Philips North America LLC | $13.56 | 2022 | |
| Kci USA, INC. | $12.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Dietz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.